3Bouros D,and Antoniou KM.Current and future therapeutic approaches in idiopathic pulmonary fibrosis[].European Respiratory Journal.2005
4Demedts,M,Behr,J,Buhl,R.High-dose acetylcysteine in idiopathic pulmonary fibrosis[].The New England Journal of Medicine.2005
5Behr J,Degenkolb B,Krombach F,et al.Intracellular glutathione and bronchoalveolar cells in fibrosin galveolitis:effects of N-acetylcysteine[].European Respiratory Journal.2002
二级参考文献30
1D'Agostini F,Bagnasco M,Giunciuglio D,et al.Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia,and prevention of primary tumors and lung micrometastases in mice.Int J Oncol,1998,13:217-224.
2Conaway CC,Jiao D,Kelloff GJ,et al.Chemopreventive potential of fumaric acid,N-acetylcysteine,N-(4-hydroxyphenyl) retinamide and beta-carotene for tobacco- nitrosamine-induced lung tumors in A/J mice.Cancer Lett,1998,124:85-93.
3Riise GC,Qvarfordt I,Larsson S,et al.Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro.Respiration,2000,67:552-558.
4Behr J,Maier K,Degenkolb,B,et al.Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis.Adjunctive therapy to maintenance immunosuppression.Am J Respir Crit Care Med,1997,156:1897-1901.
6Stey C,Steurer J,Bachmann S,et al.The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review.Eur Respir J,2000,16:253-262.
7Balansky RM,De Flora S.Chemoprevention by N-acetylcysteine of urethane-induced clastogenicity and lung tumors in mice.Int J Cancer,1998,77:302-305.
8Riise GC,Larsson S,Larsson P,et al.The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy? Eur Respir J,1994,7:94-101.
9Pela R,Calcagni AM,Subiaco S,et al.N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD.Respiration,1999,66:495-500.
10Serrano-Mollar A,Closa D,Cortijo J,et al.P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetylcysteine.Thorax,2002,57:629-634.
8Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am I Respir Crit Care Med, 2011, 183(6): 788-824.
9BjorakerJA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. AmJ Respir Crit Care Med, 1998, 157(1): 199-203.
10Demedts M, BehrJ, Buhl R, et al. High-dose acetylcysteine in idi- opathic pulmonary fibrosis. N Engl 1 Med, 2005, 353(21): 2229-2242.
